Synektik

Synektik Operating Cash Flow

The Operating Cash Flow of Synektik (SNT.WA) as of Oct 31, 2026 is 77.73 M PLN. In the previous year, Operating Cash Flow was 89.61 M PLN — a change of -13.26% (lower).

Operating Cash Flow

77.73 MPLN

YoY

-13.26%

Last updated:

Operating Cash Flow of Synektik is 2025 77.73 M PLN. Operating Cash Flow of Synektik was 2024 89.61 M PLN. It decreases by -13.26% lower compared to the previous year.

The Synektik Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
5.22 M PLN
Jan 1, 2019
13.55 M PLN
Jan 1, 2020
13.93 M PLN
Jan 1, 2021
21.71 M PLN
Jan 1, 2022
-6.18 M PLN
Jan 1, 2023
94.49 M PLN
Jan 1, 2024
89.61 M PLN
Jan 1, 2025
77.73 M PLN
The Synektik Operating Cash Flow history
YEAROperating Cash FlowYoY
77.73 MPLN-13.26%
89.61 MPLN-5.17%
94.49 MPLN-1,628.09%
-6.18 MPLN-128.48%
21.71 MPLN+55.88%
13.93 MPLN+2.81%
13.55 MPLN+159.30%
5.22 MPLN-64.15%
14.57 MPLN-280.75%
-8.06 MPLN-240.87%
5.72 MPLN-52.16%
11.96 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Operating Cash Flow of Synektik is 77.73 M PLN in 2025.

Operating Cash Flow of Synektik changed from 89.61 M PLN to 77.73 M PLN, representing a -13.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Synektik since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Synektik historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Synektik

All Key Metrics — Synektik